YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Isolation and Identification of an Unauthorized Tadalafil Analogue in a Commercial Functional Food

시판 기능성식품으로부터의 타다라필 유도체 부정첨가물질의 분리 및 구조규명

  • Baek, Du-Jong (Department of Chemistry, College of Natural Sciences, Sangmyung University)
  • 백두종 (상명대학교 자연과학대학 화학과)
  • Received : 2010.03.31
  • Accepted : 2010.05.28
  • Published : 2010.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

High-performance liquid chromatography (HPLC) screening method revealed that a propolis product marketed as a functional food contained an undeclared substance similar to tadalafil, the active ingredient of the prescription drug Cialis$^{(R)}$ approved for the treatment of male erectile dysfunction. In order to identify the illegal additive, the propolis product was extracted with methylene chloride, and the extract was purified further using semipreparative HPLC. The chemical structure of the isolated substance was elucidated based on IR, LC/MS-ESI, and $^1H$- and $^{13}C$-NMR spectroscopy, which showed the characteristics similar to tadalafil. The only difference was the substitution of the methyl group at the piperazinedione ring of tadalafil to the amino group of the identified illegal additive.

Keywords

References

  1. Brock, G. B., McMahon, C. G., Chen, K. K., Costigan, T., Shen, W., Watkins, V., Anglin, G. and Whitaker II, S. : Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J. Urol. 168, 1332 (2002). https://doi.org/10.1016/S0022-5347(05)64442-4
  2. Kloner, R. A., Hutter, A. M., Emmick, J. T., Mitchel, M. I., Denne, J. and Jackson, G. : Time course of the interaction between tadalafil and nitrates. J. Am. Coll. Cardiol. 42, 1855 (2003). https://doi.org/10.1016/j.jacc.2003.09.023
  3. 식품위생법 제6조(기준.규격이 고시되지 아니한 화학적 합성품 등의 판매 등 금지).
  4. 장재희, 박건상, 박혜경, 구용의, 최윤주, 황인경, 김대병 : 식품 중 불법 함유된 발기부전치료제 성분 검출을 위한 동시분석법 연구. 한국식품위생안전성학회지 18, 195 (2003).
  5. Graz, S. R., Flurer, C. L. and Wolnik, K. A. : Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. J. Pharm. Biomed. Anal. 36, 525 (2004). https://doi.org/10.1016/j.jpba.2004.07.004
  6. 식품 중 부정유해물질분석 매뉴얼 (행정간행물등록번호 11- 1470000-00839-14), 식품의약품안전청 (2005).
  7. Laboratoires Glaxo S. A., France, Tetracyclic Derivatives, Process of Preparation and Use, WO 95/19978 (July 27, 1995).
  8. Lilly Icos LLC, Chemical Compounds, WO 02/00656 A2 (Jan. 3, 2002).